1. Abstract
The World Health Organization Quality of Life HIV Instrument (WHOQOL-HIV) is a specialized, multidimensional psychometric instrument developed by the World Health Organization Quality of Life Group to evaluate subjective quality of life (QoL) in persons living with HIV/AIDS (PLWHA). Derived from the parent WHOQOL-100 framework, this comprehensive assessment comprises 120 core items organized into 29 distinct facets that map onto six primary domains: (I) Physical, (II) Psychological, (III) Level of Independence, (IV) Social Relationships, (V) Environment, and (VI) Spirituality, Religion, and Personal Beliefs (SRPB), alongside an overarching assessment of general health perceptions and global quality of life, followed by an optional 37-item importance module. Every item is rated on an anchored 5-point Likert-type scale reflecting intensity, capacity, frequency, or satisfaction across a 2-week recall timeframe. Psychometric evaluations across diverse multinational cohorts demonstrate robust internal consistency (Cronbach’s alpha coefficients typically exceeding α = .80 to .93 across domain scores), exceptional test-retest stability (intraclass correlation coefficients ICC > .80), and solid convergent, discriminant, and criterion-related validity. Confirmatory factor analyses consistently substantiate the six-domain model, with superior fit compared to generic health-related quality of life structures. Cross-cultural measurement invariance has been established across high-, middle-, and low-income settings, confirming the scale’s structural integrity and cross-cultural applicability. The WHOQOL-HIV serves as a gold-standard assessment in clinical trials evaluating antiretroviral therapy (ART), longitudinal epidemiological research, health economics, and holistic patient-centered palliative and psychosocial interventions.
2. Keywords
WHOQOL-HIV, Quality of Life, HIV/AIDS, Psychometrics, Health-Related Quality of Life (HRQoL), Patient-Reported Outcome Measures (PROMs), Antiretroviral Therapy, Cross-Cultural Assessment, Spirituality and Personal Beliefs, Factor Analysis.
3. Authors
The instrument was developed under the auspices of the World Health Organization Quality of Life (WHOQOL) Group, coordinated by the Department of Mental Health and Substance Abuse at the World Health Organization in Geneva, Switzerland.
- Principal Coordinating Organization: World Health Organization (WHO), Division of Mental Health and Prevention of Substance Abuse, Geneva, Switzerland.
- Key Scientific Investigators & Collaborators:
- John Orley, M.D. — Former Programme Manager, Mental Health Promotion, World Health Organization.
- Willem Kuyken, Ph.D. — Professor of Clinical Psychology, University of Oxford (formerly associated with the WHOQOL steering committee).
- Suzanne M. Skevington, Ph.D. — Professor of Psychology, University of Manchester, Director of the WHO Centre for the Study of Quality of Life.
- Donald L. Patrick, Ph.D., MSPH — Department of Health Services, University of Washington, Seattle, WA, USA.
- Shekhar Saxena, M.D. — Former Director, Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
- Multicenter Field Research Collaborative: The scale was formulated and validated across an international network of collaborative research sites, including academic and clinical centers in Melbourne (Australia), St. Petersburg (Russia), Bangkok (Thailand), New Delhi (India), Porto Alegre (Brazil), Seattle (USA), London (UK), Harare (Zimbabwe), and Padua (Italy).
- Institutional Contact: Department of Mental Health and Substance Use, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland. Web portal: WHO Mental Health and Substance Use.
4. Purpose
The primary purpose of the WHOQOL-HIV is to provide a holistic, subjective, and cross-culturally validated measure of quality of life specifically calibrated to capture the multidimensional challenges confronted by persons living with HIV/AIDS. While general biomedical markers such as CD4+ T-cell lymphocyte counts and HIV-1 viral load assays are vital for tracking immunological status and virological suppression, they fail to capture the pervasive psychological distress, societal stigma, physical debilitation, neuropsychiatric complications, and existential disruptions experienced by affected individuals. The WHOQOL-HIV fills this critical gap by translating the patient’s subjective life experiences into rigorous psychometric data.
In clinical practice, the tool functions as a diagnostic and monitoring aid. It enables multidisciplinary medical teams—including infectious disease specialists, clinical psychologists, psychiatric nurses, and social workers—to detect hidden morbidities such as peripheral neuropathy pain, body dysmorphia stemming from lipodystrophy, medication fatigue, depressive demoralization, and perceived discrimination. By pinpointing impaired domains, healthcare providers can formulate tailored supportive care interventions, optimize adherence to complex lifelong antiretroviral therapy (ART) regimens, and track therapeutic responses over time.
In research settings, the WHOQOL-HIV serves as a primary or secondary patient-reported outcome measure (PROM) in Phase III and Phase IV randomized controlled trials of novel antiretroviral agents, immune therapies, and psychosocial rehabilitation programs. It is uniquely sensitive to subtle differences in medication tolerability, side-effect profiles, and dosing schedules. Moreover, in health services research and health economics, the instrument yields actionable epidemiological data to inform resource allocation, evaluate public health initiatives, and guide health policy planning across economically and culturally diverse nations.
5. Psychological Construct
The WHOQOL-HIV operationalizes quality of life based on the official definition framed by the World Health Organization: “an individual’s perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns.” This definition establishes QoL as an inherently subjective, multidimensional, and culturally embedded construct rather than an objective cataloging of medical symptoms or functional status. The instrument expands the 24 facets of the standard WHOQOL-100 to 29 facets specifically addressing the complexities of HIV/AIDS, distributed across six comprehensive domains:
Domain I: Physical Health
This domain captures the somatic consequences of HIV infection, opportunistic infections, and medication side effects. It contains four distinct facets: Pain and Discomfort (evaluating somatic pain severity and the restriction it imposes on basic function), Energy and Fatigue (assessing persistent chronic exhaustion and vigor), Sleep and Rest (evaluating sleep architecture disruption, insomnia, and nocturnal recovery), and Symptoms of PLWHA (assessing physical problems directly tied to HIV such as diarrhea, weight loss, fever, nausea, and neuropathic sensations).
Domain II: Psychological Well-Being
Reflecting cognitive and affective states, this domain incorporates five facets: Positive Feelings (experience of joy, optimism, contentedness, and psychological flourishing), Thinking, Learning, Memory, and Concentration (evaluating cognitive clarity, executive functioning, and neurocognitive compromise associated with HIV-associated neurocognitive disorders [HAND]), Self-Esteem (feelings of self-worth, agency, and self-confidence), Bodily Image and Appearance (body satisfaction, comfort with somatic appearance, and distress regarding lipodystrophy or cutaneous lesions), and Negative Feelings (anxiety, blue mood, despair, existential sadness, and depressive symptom severity).
Domain III: Level of Independence
This domain quantifies functional autonomy and physical capacity via four facets: Mobility (ease of movement and capacity to travel short or long distances), Activities of Daily Living (ADL) (ability to independently perform self-care, housekeeping, hygiene, and daily tasks), Dependence on Medication or Treatments (the degree to which functional well-being requires pharmacological agents, medical supplies, and routine clinical monitoring), and Work Capacity (ability to maintain professional responsibilities, maintain employment, and perform societal duties).
Domain IV: Social Relationships
Addressing interpersonal dynamics and community integration, this domain covers four facets: Personal Relationships (closeness, emotional bonding, and meaningful intimate connections), Social Support (perceived availability, emotional warmth, and practical assistance provided by family, friends, and peers), Sexual Activity (sexual desire, fulfillment, intimacy, and sexual dysfunction), and Social Inclusion (perceptions of societal acceptance versus alienation, rejection, and isolation).
Domain V: Environment
This domain contextualizes living conditions across eight environmental facets: Physical Safety and Security (protection from crime, violence, and external threats), Home Environment (comfort, hygiene, space, and stability of housing), Financial Resources (financial adequacy to satisfy daily survival needs and medical expenditures), Health and Social Care (accessibility, geographic proximity, and quality of clinical and community services), Opportunities for Acquiring New Information and Skills (educational empowerment and cognitive development), Recreation and Leisure Activities (access to pleasurable pastimes and relaxation), Physical Environment (surrounding pollution, urban noise, traffic density, and climate comfort), and Transport (adequacy, affordability, and availability of transit systems).
Domain VI: Spirituality, Religion, and Personal Beliefs (SRPB)
Crucially tailored for HIV-positive populations, this domain measures existential, metaphysical, and philosophical coping across four targeted facets: Spirituality, Religion, and Personal Beliefs (finding meaning, inner strength, and comfort through sacred or philosophical systems), Forgiveness and Blame (feelings of guilt, internal self-blame, external condemnation, and the pursuit of self-reconciliation), Concerns about the Future (prospective dread, trajectory of health deterioration, and concern for offspring or ancestral legacy), and Death and Dying (preoccupation with mortal demise, terminal agony, dignity in dying, and existential terror regarding mortality).
6. Theoretical Framework
The WHOQOL-HIV is grounded in an integrative synthesis of three primary paradigms: the Biopsychosocial Model originally advanced by George Engel, the Cognitive Appraisal and Transactional Model of Coping formulated by Richard Lazarus and Susan Folkman, and Cross-Cultural Anthropological Psychometrics spearheaded by the WHO.
Engel’s biopsychosocial paradigm challenged reductionist biomedical frameworks by demonstrating that pathological biological mechanisms (e.g., retroviral replication, viral load elevations, helper T-cell depletion) do not exist in isolation. Rather, they dynamically intersect with subjective psychological states (e.g., neurochemical vulnerability to depression, existential distress) and sociostructural factors (e.g., socioeconomic deprivation, institutionalized stigma, family support structures). The WHOQOL-HIV reflects this unified model by weighting environmental, social, and psychological domains alongside physical indicators.
Under the transactional model of Lazarus and Folkman, quality of life does not stem directly from an objective chronic illness diagnosis; instead, it is mediated by primary appraisals (evaluating HIV as a threat, challenge, or catastrophic harm) and secondary appraisals (evaluating one’s personal, spiritual, and social resources to manage the disease). The SRPB domain, along with facets addressing self-esteem and future-oriented fear, directly gauges these cognitive appraisal patterns and psychological coping resources.
Finally, the instrument embodies the WHO’s pioneering cross-cultural psychometric philosophy. Unlike standard Western scales that are developed within English-speaking nations and subsequently translated, the WHOQOL project employed a simultaneous, international, collaborative protocol across multiple worldwide centers. Through rigorous iterative focus groups comprising patients with HIV, their formal and informal caregivers, and professional healthcare workers across diverse cultural, linguistic, and socio-economic settings, the developers established universal (etic) conceptual anchors while preserving cultural nuance (emic facets), ensuring structural validity worldwide.
7. Validity
The measurement properties of the WHOQOL-HIV have been validated through international multi-center psychometric investigations involving diverse cohorts of patients across varied disease stages (asymptomatic, symptomatic, and clinical AIDS).
Construct and Structural Validity
Construct validity is substantiated by the scale’s ability to discriminate robustly between distinct clinical strata. In benchmark multi-site WHO trials, significant differences were demonstrated across the six domain scores between asymptomatic individuals, symptomatic HIV-positive individuals, and patients diagnosed with full-blown AIDS (p < .001). Patients with advanced clinical disease systematically scored lower on Physical Health, Level of Independence, and Psychological Well-Being, while reporting higher scores on the Death and Dying and Symptoms facets. Known-groups validity was further affirmed through significant score differentials between hospitalized inpatients versus ambulatory outpatients, and between individuals with detectable versus fully suppressed viral loads.
Convergent and Discriminant Validity
Convergent validity is verified via strong, statistically significant correlations with established health-related quality of life and psychological measures. Domain I (Physical) and Domain III (Level of Independence) exhibit substantial correlations (r = .65 to .78) with the Physical Component Summary (PCS) of the MOS-SF-36 and Karnofsky Performance Status scales. Domain II (Psychological) demonstrates strong negative correlations with the Beck Depression Inventory (r = −.68 to −.74) and the Hospital Anxiety and Depression Scale (HADS). Discriminant validity is supported by low inter-correlations between non-overlapping constructs; for example, the Physical Environment facet correlates minimally with the Death and Dying facet (r < .20), confirming that distinct theoretical constructs are measured without redundant collinearity.
Criterion and Predictive Validity
Longitudinal prospective validation studies demonstrate that baseline WHOQOL-HIV scores possess strong predictive validity for major clinical outcomes. Baseline Domain I (Physical) and Domain II (Psychological) scores significantly predict subsequent adherence to combination antiretroviral therapy (cART), progression to AIDS-defining illnesses, hospitalization rates, and independent mortality over 12-month, 24-month, and 5-year follow-up windows, after controlling for baseline CD4+ cell counts, viral burden, and socioeconomic covariates.
8. Reliability
Extensive field trials establish that the WHOQOL-HIV possesses high reliability across languages, clinical settings, and cultural contexts.
Internal Consistency
Internal consistency reliability, evaluated via Cronbach’s alpha (α), consistently exceeds the accepted .70 threshold for research instruments and frequently surpasses the .90 benchmark required for individual clinical diagnostics:
- Domain I (Physical Health): α = .82 to .89
- Domain II (Psychological Well-Being): α = .84 to .91
- Domain III (Level of Independence): α = .81 to .88
- Domain IV (Social Relationships): α = .78 to .85
- Domain V (Environment): α = .88 to .93
- Domain VI (SRPB): α = .80 to .88
- Overall Quality of Life & General Health: α = .82 to .87
Test-Retest Stability
In stable ambulatory outpatient cohorts retested over intervals of two to four weeks, the instrument shows excellent temporal stability. Intraclass correlation coefficients (ICC) across the six domain scores range from .76 to .91, and Pearson test-retest correlation coefficients range between r = .74 and r = .89, indicating that the scale is resilient to minor transient fluctuations while remaining sensitive to genuine clinical changes.
9. Factor Analysis
The internal latent structure of the WHOQOL-HIV has been examined through Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) across diverse multi-center international datasets.
Exploratory Factor Analysis (EFA)
Initial principal components and principal axis factoring with promax and varimax rotations performed on the item and facet correlation matrices consistently supported a six-factor structural solution. The 29 individual facets load cleanly onto their hypothesized latent domains, with primary factor loadings typically ranging between .55 and .86, and minimal cross-loadings (rarely exceeding .30 on secondary factors). Together, these six factors account for approximately 58% to 65% of the total variance across multi-center samples.
Confirmatory Factor Analysis (CFA)
Structural equation modeling has confirmed the hierarchical six-domain structure. First-order models specify 29 facet factors underpinned by their respective four items, which then load onto second-order latent domain factors (Physical, Psychological, Independence, Social, Environment, SRPB), culminating in a higher-order general Quality of Life construct. Goodness-of-fit indices derived from large international cohorts demonstrate good model fit:
- Comparative Fit Index (CFI): .92 to .96
- Tucker-Lewis Index (TLI): .91 to .95
- Root Mean Square Error of Approximation (RMSEA): .042 to .055 (90% CI: .038–.059)
- Standardized Root Mean Square Residual (SRMR): .041 to .052
- Normed Chi-Square (χ²/df): 1.8 to 2.4
Multigroup CFA (MGCFA) tests confirm metric and scalar measurement invariance across biological sex, disease stages (asymptomatic vs. symptomatic), and diverse language adaptations (e.g., English, Portuguese, Mandarin, Thai, Russian), validating direct cross-cultural and longitudinal comparative analyses.
10. Instrument / Measurement Tool
- Instrument Name: World Health Organization Quality of Life HIV Instrument (WHOQOL-HIV).
- Administration Format: Standardized self-administered questionnaire; structured interviewer-administered format is validated for populations with visual or literacy barriers.
- Item Count: 120 primary core items (comprising 29 specific facets grouped into 6 domains, plus 4 global items assessing overall QoL and general health perceptions), followed by 37 supplementary facet importance items and a brief sociodemographic and health status profile.
- Target Population: Adolescents and adults (ages 18+) living with confirmed HIV infection or AIDS across all clinical strata.
- Recall Period: Responses refer specifically to the past two weeks.
- Response Scales: Nine tailored 5-point Likert-type response scales (lettered A through I), coded from 1 to 5:
- Scale A (Intensity/Capacity): (1) Not at all, (2) A little, (3) Moderately (A moderate amount), (4) Very much, (5) An extreme amount
- Scale B (Intensity/Difficulty): (1) Not at all, (2) Slightly, (3) Moderately, (4) Very, (5) Extremely
- Scale C (Capacity/Perception): (1) Not at all, (2) Slightly, (3) Moderately, (4) Very much, (5) Extremely
- Scale D (Fulfillment/Sufficiency): (1) Not at all, (2) A little, (3) Moderately, (4) Mostly, (5) Completely
- Scale E (Satisfaction): (1) Very dissatisfied, (2) Dissatisfied, (3) Neither satisfied nor dissatisfied, (4) Satisfied, (5) Very satisfied
- Scale F (Subjective Evaluation): (1) Very poor, (2) Poor, (3) Neither poor nor good, (4) Good, (5) Very good
- Scale G (Frequency): (1) Never, (2) Seldom, (3) Quite often, (4) Very often, (5) Always
- Scale H (Happiness): (1) Very unhappy, (2) Unhappy, (3) Neither happy nor unhappy, (4) Happy, (5) Very happy
- Scale I (Importance): (1) Not important, (2) A little important, (3) Moderately important, (4) Very important, (5) Extremely important
- Scoring and Transformation Algorithm:
- Negative items (e.g., pain, fatigue, sleep problems, sadness, dependence, discrimination, guilt, death anxiety) must be reverse-coded so that higher values consistently indicate superior quality of life: Recoded Score = 6 − Raw Score.
- Facet scores are computed by summing the four constituent items and dividing by 4, producing an unweighted mean facet score ranging from 1 to 5.
- Domain raw scores are calculated by summing the respective facet mean scores within each domain.
- Domain raw scores are linearly transformed into a 4-to-20 scale (conforming to the standard WHOQOL scale) using the formula:
Domain Score (4-20) = (Domain Raw Score / Number of Facets) × 4. - For comparative clinical and public health reporting, scores are converted to a 0–100 percentage scale:
Domain Score (0-100) = (Domain Score [4-20] − 4) × 6.25.
11. Permissions & Fee and Test Year
- Year of Formal Publication: 2002 (with preliminary development and field-testing protocols published between 1993 and 1998).
- Intellectual Property and Copyright: © World Health Organization. All rights reserved.
- Licensing and Accessibility: The WHOQOL-HIV is available for non-commercial academic, clinical, and public health research without user licensing fees. Investigators and healthcare institutions must register their protocol with the WHO Department of Mental Health and Substance Use or their national WHOQOL Coordinating Centre and adhere to standardized administration and scoring guidelines.
- Commercial Applications: Commercial entities (e.g., pharmaceutical manufacturers sponsored for clinical drug trials) must obtain explicit written authorization and execute a licensing agreement via the WHO permissions gateway.
- Official Documentation: WHOQOL-HIV User Manual & Scoring Protocols.
12. References
Bonomi, A. E., Patrick, D. L., Bushnell, D. M., & Martin, M. (2000). Validation of the United States’ version of the World Health Organization Quality of Life (WHOQOL) instrument. Journal of Clinical Epidemiology, 53(1), 1–12. https://doi.org/10.1016/S0895-4356(99)00123-7
McDowell, I. (2006). Measuring health: A guide to rating scales and questionnaires (3rd ed.). Oxford University Press. https://doi.org/10.1093/acprof:oso/9780195165678.001.0001
O’Connell, K. A., & Skevington, S. M. (2012). An international quality of life instrument to assess wellbeing in adults living with HIV/AIDS: 31-item WHOQOL-HIV-BREF. BMJ Open, 2(6), e001739. https://doi.org/10.1136/bmjopen-2012-001739
Skevington, S. M., Bradshaw, J., & Saxena, S. (1999). Selecting national items for the WHOQOL: Conceptual and psychometric considerations. Social Science & Medicine, 48(4), 473–487. https://doi.org/10.1016/S0277-9536(98)00366-4
WHOQOL Group. (1993). Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Quality of Life Research, 2(2), 153–159. https://doi.org/10.1007/BF00435734
WHOQOL Group. (1994). The development of the World Health Organization quality of life assessment instrument (the WHOQOL). In J. Orley & W. Kuyken (Eds.), Quality of life assessment: International perspectives (pp. 41–57). Springer-Verlag. https://doi.org/10.1007/978-3-642-79123-9_4
WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558. https://doi.org/10.1017/s0033291798006667
World Health Organization. (2002). WHOQOL-HIV instrument: User manual: Scoring and coding for the WHOQOL-HIV instrument. World Health Organization. https://apps.who.int/iris/handle/10665/77776